COMMUNIQUÉS West-GlobeNewswire

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

06/08/2024 - 22:05

- Announced partnership with ProGen on development of RT-114, an oral GLP-1/GLP-2 dual agonist for the treatment of obesity - - Phase 1 study for RT-114 expected to initiate in 2025 - - Completed equity offering with [...]

Treace Medical Concepts Reports Second Quarter 2024 Financial Results

06/08/2024 - 22:05

PONTE VEDRA, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update

06/08/2024 - 22:05

Revenues increased 45% compared to the previous quarter ended March 31, 2024 Optimized LungFit PH device continues to expand footprint and strengthen customer base Amir Avniel, Beyond Air Board member and Chief Business [...]

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06/08/2024 - 22:05

WALTHAM, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity [...]

BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024

06/08/2024 - 22:05

MELVILLE, N.Y., Aug. 06, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today [...]

OraSure Reports Q2 ’24 Revenue of $54.3 Million

06/08/2024 - 22:05

Q2 GAAP EPS of $(0.01) ; Q2 Non-GAAP EPS of $0.07 OraQuick® HCV Self-test is the first globally to earn WHO pre-qualification Strong momentum with Syphilis Health Check™ launch Expanding Sample Management applications [...]

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

06/08/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update

06/08/2024 - 22:05

-- VAX-31 Adult Phase 1/2 Study Topline Safety, Tolerability and Immunogenicity Data Expected in September 2024 -- -- Following VAX-31 Adult Phase 1/2 Study Results, Vaxcyte to Advance VAX-24 or VAX-31 to Adult Phase 3 [...]

FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update

06/08/2024 - 22:05

Company implementing significant cost reduction plan in the U.S. due to results in late-stage pamrevlumab pancreatic cancer trials, including a reduction of U.S. workforce by approximately 75% Focus R&D investment [...]

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024

06/08/2024 - 22:05

Completed enrollment in batoclimab pivotal Myasthenia Gravis (MG) trial; top-line results and initiation of a potentially registrational program for IMVT-1402 on track for fiscal year end (March 31, 2025) Progressed [...]

PetMeds® Announces Fiscal 2025 First Quarter Financial Results

06/08/2024 - 22:05

Net Income for first quarter fiscal 2025 was $3.8 million or $0.18 diluted earnings per share DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx ( [...]

Cytek Biosciences Reports Second Quarter 2024 Financial Results

06/08/2024 - 22:05

FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second [...]

Pennant Reports Second Quarter 2024 Results

06/08/2024 - 22:05

Conference Call and Webcast scheduled for tomorrow, August 7, 2024 at 10:00 am MT EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of [...]

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

06/08/2024 - 22:05

Highlights Second quarter revenue grew 15% year-over-year to $212 million , driven by Prenatal ( 25% ), Pharmacogenomics ( 22% ), and Hereditary Cancer ( 19% ). Second quarter GAAP earnings per share improved to $(0.41 [...]

Cognos Therapeutics Announces Formation of Industry Advisory Board

06/08/2024 - 22:05

Mark Webster Appointed Co-Chair of Advisory Board INGLEWOOD, CA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics (“Cognos” and “the Company”), a leading innovator in medical technology, today proudly announced the [...]

Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

06/08/2024 - 22:03

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Keith Cummings, M.D., Chief Financial Officer, and Éric Lefebvre, M.D., Chief Medical Officer [...]

Progyny, Inc. Announces Second Quarter 2024 Results

06/08/2024 - 22:02

Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion Rate Board Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny [...]

Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program

06/08/2024 - 22:02

MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally [...]

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

05/08/2024 - 22:36

MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]